Prescription Drug Monitoring Program: Georgia State Profile

• NCJ Number: 252995
• Date Published: September 2018
• Length: 8 pages
• Sponsoring Agency: Bureau of Justice Assistance (BJA)
• Corporate Author: Brandeis University
• Sale Source: Bureau of Justice Assistance (BJA)
• Publication Format: Document; Document (Online)
• Publication Type: Report (Technical Assistance); Report (Summary); Report (Grant Sponsored); Program/Project Description; Legislative/Regulatory Material; Legislation/Policy Description
• Language: English
• Country: United States of America

Annotation

Comprehensive data and information are provided for Georgia's Prescription Drug Monitoring Program (GA PDMP).

Abstract

The administering agency for the GA PDMP is the Georgia Department of Public Health. The home website address is provided, along with website addresses for enrollment, queries, and data upload. Contact information is provided for the PDMP Director. PDMP data for 2017 cover the state population (10,545,138), DEA registered prescribers (40,836), and registered dispensers (2,368). PDMP available reports are listed. For 2018, funding sources are listed as the state general fund and a grant from the Centers for Disease Control (CDC). The number of PDMP employees by task category in 2018 were as follows: operational (5), technical (0), analytical (2), and "other" (0). Data on policies and procedures include important PDMP dates. These include data of authorizing legislation (May 2011), when it became operational (July 2013), initial user access (July 2013), online access (July 2013), and electronic monitoring (July 2013. Sources for relevant statutes and rules are listed. Data reporting frequency is 1 day. The drugs monitored are controlled substances in schedules II, III. IV, and V. Miscellaneous capabilities and policies are listed. Prescribers and dispensers of drugs are required to be enrolled in the PDMP, and prescribers are required to use it. Each physician owning or practicing in a pain management clinic must regularly check the PMP on all new and existing patients and when first prescribing a controlled substance or benzodiazepines and thereafter once every 90 days. Requirements for law enforcement personnel's interaction with the PMP are provided, along with access methods. Other information on the GA PDMP addresses requestor training requirements and available training (none indicated), technological capabilities, and requestors and reports authorized to be generated and those that are available.